Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
Krystal Biotech (NASDAQ: KRYS) will report third quarter 2025 financial results on Monday, November 3, 2025, before the U.S. market open. Management will host a conference call and webcast at 8:30 am ET on November 3 to discuss results and provide a business update.
Investors can access the live webcast at https://www.webcaster5.com/Webcast/Page/3018/53113. A replay will be available for at least 30 days on the Investors section of the company website at www.krystalbio.com.
Krystal Biotech (NASDAQ: KRYS) riferirà i risultati finanziari del terzo trimestre 2025 il lunedì 3 novembre 2025, prima dell'apertura del mercato statunitense. Il management organizzerà una conference call e una webcast alle 8:30 ET il 3 novembre per discutere i risultati e fornire un aggiornamento sull'attività.
Gli investitori possono accedere al webcast in diretta all'indirizzo https://www.webcaster5.com/Webcast/Page/3018/53113. Una registrazione sarà disponibile per almeno 30 giorni nella sezione Investitori del sito web dell'azienda all'indirizzo www.krystalbio.com.
Krystal Biotech (NASDAQ: KRYS) reportará los resultados financieros del tercer trimestre de 2025 el lunes 3 de noviembre de 2025, antes de la apertura del mercado de EE. UU. La dirección organizará una llamada de conferencia y una webcast a las 8:30 a. m. hora del este el 3 de noviembre para discutir los resultados y proporcionar una actualización comercial.
Los inversores pueden acceder al webcast en directo en https://www.webcaster5.com/Webcast/Page/3018/53113. Una réplica estará disponible durante al menos 30 días en la sección de Inversores del sitio web de la empresa en www.krystalbio.com.
Krystal Biotech (NASDAQ: KRYS)는 2025년 3분기 재무 실적을 2025년 11월 3일 월요일 미국 시장 개장 전 발표할 예정입니다. 경영진은 11월 3일 동부 표준시 8:30에 컨퍼런스 콜 및 웹캐스트를 주최하여 결과를 논의하고 비즈니스 업데이트를 제공합니다.
투자자들은 라이브 웹캐스트에 https://www.webcaster5.com/Webcast/Page/3018/53113에서 접속할 수 있습니다. 재방송은 회사 웹사이트의 투자자 섹션에서 최소 30일 동안 이용 가능하며 www.krystalbio.com에서 확인할 수 있습니다.
Krystal Biotech (NASDAQ: KRYS) publiera les résultats financiers du troisième trimestre 2025 le lundi 3 novembre 2025, avant l’ouverture des marchés américains. La direction animera une conférence téléphonique et une webcast à 8h30 ET le 3 novembre pour discuter des résultats et fournir une mise à jour commerciale.
Les investisseurs peuvent accéder à la webcast en direct sur https://www.webcaster5.com/Webcast/Page/3018/53113. Une rediffusion sera disponible pendant au moins 30 jours dans la section Investisseurs du site de l’entreprise www.krystalbio.com.
Krystal Biotech (NASDAQ: KRYS) wird die Finanzergebnisse des dritten Quartals 2025 am Montag, dem 3. November 2025, vor der Eröffnung des US-Marktes bekannt geben. Das Management wird am 3. November um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Geschäftsupdate zu geben.
Investoren können den Live-Webcast unter https://www.webcaster5.com/Webcast/Page/3018/53113 aufrufen. Eine Wiedergabe wird mindestens 30 Tage auf der Investoren-Seite der Unternehmenswebsite unter www.krystalbio.com verfügbar sein.
Krystal Biotech (NASDAQ: KRYS) سيُبلغ عن نتائج الربع الثالث من عام 2025 في يوم الإثنين 3 نوفمبر 2025، قبل افتتاح السوق الأمريكية. سيُعقد اتصال هاتفي وبث ويب من قبل الإدارة في 8:30 صباحاً بتوقيت شرق الولايات المتحدة في 3 نوفمبر لمناقشة النتائج وتقديم تحديث للأعمال.
يمكن للمستثمرين الوصول إلى البث المباشر عبر الويب في https://www.webcaster5.com/Webcast/Page/3018/53113. ستتوفر إعادة تشغيل لمدة لا تقل عن 30 يوماً في قسم المستثمرين من موقع الشركة على الويب www.krystalbio.com.
Krystal Biotech (NASDAQ: KRYS) 将在 2025 年第三季度 的财务结果于 2025 年 11 月 3 日，星期一 美国市场开盘前发布。管理层将于 11 月 3 日举行一个电话会议和网络广播，时间为 美东时间 8:30，讨论业绩并提供业务更新。
投资者可以通过 https://www.webcaster5.com/Webcast/Page/3018/53113 访问实时网络广播。网站的投资者栏目至少会提供 30 天 的重播，地址为 www.krystalbio.com。
- None.
- None.
PITTSBURGH, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its third quarter 2025 financial results on Monday, November 3, 2025, prior to the open of U.S. markets.
The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, November 3, 2025, to discuss the financial results and provide a business update.
Investors and the general public can access the live webcast at: https://www.webcaster5.com/Webcast/Page/3018/53113.
For those unable to listen to the live webcast, a replay will be available for at least 30 days on the Investors section of the Company’s website at www.krystalbio.com.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK®, the Company’s first commercial product, is the first-ever redosable gene therapy, and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette, PhD
Krystal Biotech
spaquette@krystalbio.com
FAQ
When will Krystal Biotech (KRYS) report Q3 2025 results?
What time is the Krystal Biotech (KRYS) earnings call on November 3, 2025?
Where can I watch the Krystal Biotech (KRYS) live webcast for Q3 2025?
Will Krystal Biotech (KRYS) provide a replay of the Q3 2025 webcast?
How can investors access the Krystal Biotech (KRYS) business update on November 3, 2025?
